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ABSTRACT
Inhibition of Synaptosomal Biogenic Amine Transp o rt
by a Diverse Group of Neurotoxic Chemicals
by
William M. Bracken, Master of Science
Utah State University, 1980
Major Professor: Dr. Raghubir P. Sharma
Department: Toxicology

Synaptosomal membrane functions were monitored, a f ter in vitro

exposure to select environtr)ental pollutants, in synaptosomal prepara-

tions originationg from rat cerebral cortices.

The uptake of NE

and SHT into the synaptosomes was monitored as was the ~-dependent
phosphatase activity of the membrane.
diisoprop y1f 1uorophosphate

CH HgC1, Hg(N0 ) , CdC1 ,
3
3 2
2

(DFP), paraoxon, acry1amide and Kepone

were the test chemicals whose effects were studied.

CH HgC1, Hg(N0 ) and Kepone had t he greatest inhib itory effects
3 2
3
on NE an d SHT uptake .
inhibition (Ic

50

The concentrations producing 50 percent

) were 1.4 x 10- 4 , 4 . 0 x 10 - 4 , and 9 . 4 x 10- S M,

respective l y , for NE uptake while the rc
4

4

1. 9 x 10- , 6. 0 x 10- , and 3. 3 x 10-

inhibiti on was 60- 100 percent at 10-

3

4

50

•s for SHT uptake were

H, respectivel y .

Maximal

M while the effective

4
concentration range was between 10- -10- 3 M.

The remaining test

compounds produced no significant inhibition at concentrations up

to 10

-3

M.

X

K+-dependent phosphatase was strongly inhibited by CH HgCl,
3
Hg(N0 ) , CdC1 , and Kepone with rc •s of 1.5 x 10- 6 , 0.032 x 10~ 6 ,
2
3 2
50
6
6
1.5 x 10- , and 13.0 x 10- M, respectively . The effective inhibitory
7
concentrations for these chemicals ranged from 10- -10- 3 M and
suggested a specific high affinity inhibition.

DFP, paraoxon and

acrylamide did not produce a significant inhibition at concentrations
between 10

-5

-10

-3

M.

A correlation of the phospha t ase and monoamine uptake inhibitions,
in search of a cause- effect relationship, was not suggested from the

data.

However, the l ow affinity inhibition

(rc 50 greater than 10- 5 M)

of the NE and SHT uptake by CH HgCl, Hg(N0 ) and Kepone, along with
3
3 2
t he general shape of the dose-response c urve is suggestive of an all or- none inhibition.
than 10-

5

The apparent high affinity inhibition

(rc 50 less

M) of the phosphatase demonstrates the specific influences

these compounds can have on enzymatic processes.

Such enzymatic

inhibition could be of critical importance if these neuro toxicants
were able to penetrate the synap t osomal or even neuronal membrane

and gain access to the metabolic and synthetic machinery.

( 107 pages)

INTRODUCTION
Federal regulations are restricting usage of many chemicals and
preventing the use of others because of positive toxicological results
in test systems .
forms:

etc.

The manifestations of toxic effects assume various

cancer, neurotoxicity, metabolic poisoning, hepatic disease,

In recent years the neurotoxic potential of chemicals has

become an increasing concern to health officials and federal agencies
regulating their use .

Mass poisonings by hexachlorobenzene, mercury,

and tri-ortho-tolyl phosphate have resulted in victims with
pathological and behavioral manifestations of neurological dysfunction (Allen et al., 1979; Harada, 1978; Smith et al . , 1930).
Widespread usage of neurotoxic pesticides has increased the exposure
and risk of both the occupational worker

and the general public .

With thousands of chemicals now in use and the continual development
of new ones, an examination of the pathological , biochemical and
physiological effects of chemicals is important for both the assessment of their need for regulation and elucidation of their mechanism
of action.

As will be detailed in a subsequent chapter, several neurotoxic
chemicals have been shown to alter neurotransmitter concentrations

and metabolism in brain tissue.

Although this relationship is

promising for the development of a definitive hypothesis for the
cause of their neurotoxicity, several problems associated with the
tissue preparation must be overcome before a complete mechanism can

2

be presented.

Studies of this nature have been performed in either

brain slices or brain homogenates making it difficult to identify
specific t ypes of target cells .

In addition tissue homogenates mask

the contribution of ionic gradients or intact plasma membranes in the
expression of the toxicity .

Disruption of the cellular compartmen-

talization in these preparations may also indirectly contribute to
the observed changes by bringing together cellular constituents,
not normall y associa t ed with the neurotransmitters, tha t i n some

non- specific manner may influence their metabolism.

To overcome these

deficiencies synap t osomal preparations can be used to monitor both
metabolism and transport processes in intact structural units that
are more indicative of the in situ conditions.

Synaptosomes are synaptic terminals which have been sheared ,
duFing fractionation, from their axonal connections and surrounding
I

glial cells.

After separation from the axon the terminal capsule

reseals forming the intact structural unit (Jones, 1975).

Often the

inter- synaptic clef t and post-synaptic process are isolated as a
portion of this unit.

Utilization of synaptosomes as a model for the

investigation of neurotransmission has several advantages.

First,

the integrit y of the membrane and demonstration of its functional
capacity is comparable to the in situ condition at the synapse .
Secondly, the characterization of their metabolic activity indicates
that all enzymes and co- factors are present as would be seen in vivo.
Thirdly, the studies showing t he viability of synaptosomes for
several hours after removal from the brain allows for the time related
studies.

A final advantage would be the characterization of synaptic

activity away from the diluting factors seen with tissue homogenate s.

3

Behavioral change is seldom util iz ed as a tool for t oxicity
t esting unless g r oss changes are apparent .

Neurotoxicity is usually

measured in terms of morphological damage rather than less apparent
biochemical lesions.

Subtle biochemical changes, although not as

lethal initially, may ultimately be just as damaging.

As will be

outlined in th e following chapter behavioral modification has been
associa t ed with altera t ions of the biogenic amine neurotransmitter
levels.

Subtle changes in these levels may not produce acute modi-

fication but if t hese changes persist ove r long periods of time it
is not known what behavioral alterations, if any, may take place .
Detrimental changes in aggres sive and r eproductive behavior, as an
example, would possibly have serious consequences for the survival of
a species.

Investigation of the effects neur otoxic chemicals may have on
neuro-transmitter function would yield valuable information concerning
possible mechanisms of action.

Parameters of concern would include

metabolism, synthesis, release and up take of t he transmitters.
Alteration in any of these processes could initiate a potentially
hazardous result and can easily be monitored in a synaptosomal model
system.

The present study is concerned with the examination of the
effects various neurotoxic environmental pollutants, from several
classifications, have on synap t ic inactivation of norepinephrine

and serotonin .

An initial characterization of the synaptosomal

preparations to determine optimum assay conditions along with a
comparison of the obtained Km and Vmax values fo r the uptake processes

4
with known literature values was performed to assess the suitability
of the synaptosomal preparations for the study.

These synaptosomes,

obtained from the cerebral cortex of the male rats were then used
to determine if in vitro exposure to the test chemicals (CH HgCl,
3
Hg(N0 ) , CdC1 , diisopropylfluorophosphate (DFP), paraoxon,
2
3 2
acrylamide and Kepone) modified the kinetics of the carrier-mediated
memb rane transport of the neurotransmitters.

K+-dependent phos-

phatase activity was monitored in the synaptosomal membrane to
determine if effects the test chemicals have on t he neurotransmitter
uptake is specific in nature or a result of a more indirect membrane

effect.
Since t he mechanism of the to xici ty of the neurotoxic agents
under study is in all probability not dependent on synaptic transport
phenomena, the present investigation will elucidate the potential
these t oxican ts have for synaptic interactions and possible behavioral
modification via an interruption of normal information flow in the
cen tral nervous system.

5

LITERATURE REVIEW
Pharmacological Modification of Central
Nervous System Functions
The brain, as an organ, is an integrated composite of many

distinct structures whose overall function is dependent on an
accurate, reproducible but flexible information flow between

individual components.
interdependency
(CNS) .

The limbic system is an example of this

that is commonly seen in the central nervous system

The total system is composed of units predominately in the

brain stem and midbrain sections (hypothalamus, basal ganglia,
amygdala, hippocampus and thalamus) joined by phylogenetically older
cerebral cortical areas (medial and ventral portions) known as the
limbic cortex .

Together these units are involved with special types

of behavior associated with emotions, subconscious motor and sensory

drives and the intrinsic feelings of pain and pleasure (Guyton, 1976).
Signals originating from parts of the limbic system other than the
hypo t halamus are funneled through the hypo t halamus and give rise to

various vegetative or behavio ral effects that are known to occur

after stimulation of the hypothalamus.

At the same time the

reticular activating system receives limbic signals to regulate

the degree of wakefulness, alertness and attention while the nonlimbic portion of the cerebral cortex receives behavioral signals
directly from t he limbic structures affecting cortical analytical
function, sensory function, and at times even its motor function .

6

To facilitate information transfer to the appropriate areas of
the brain the synaptic junction or synapse regulates the passage of
the signals from one neuron to the next.

Two key functions imparted

by this regulatory process are directionality and selectivity .
Directionality provides an organized pattern for receiving and
transmitting signals while selectivity adds a two dimensional process
that expands the range of interpretation for each signal.

Without

an inherent order in the signal processing inefficiency in information
flow would reduce the effectiveness of the integrated functions of
the nervous system.

The selective nature of the synapse occurs in

the positive and negative feedback processes which filter out
unnecessary stimuli while passing on other stimuli t hat is needed for
normal nervous function.

With the central role the synapse has in the processing of
signals within the CNS it becomes a primary target for pharmacological
manipulation . Koelle (1975) discussed the ability of selected drug
types to elicit peripheral

as well as central nervous system

responses during drug therapy.

Morphine and other opiates that produce

analgesia, drowsiness, changes in mood and mental clouding when

administered in humans, are primarily affecting higher levels of the
CNS.

Smith and Sheldon (1973) mentioned that morphine increases the

release, synthesis, and turnover of catecholamines and more recently
it has been found to compete for neuroactive peptide receptor sites

(Hughes, 1978).

Anti - psychotic drugs such as chlorpromazine

(phenothiazine type) and haloperidol (butyrophenone type) similarly
decrease depression and the psychotic states in men t ally disturbed

patients.

As yet unexplained changes are produced in normal patients

given these drugs; a decrease in motor activity and minimal responsiveness to stimuli are known to occur while inhibition of performance

on complex intellectual tests are suggested.

Biochemical monitoring

of synaptic activity showed that these anti-psychotic drugs inhibit
inactivation of nonrepinephrine and serotonin, by preventing re-uptake

into the synaptic terminals, producing a gradual decrease in monamine
concentration (Brucke et al., 1969).

Along with uptake inhibition

chlorpromazine, at low concentrations, enhances membrane permeability

in some systems suggesting that direct membrane effects may alter
the Na+ gradient required for membrane transport of the biogenic
amines (Maoi et al., 1979).

Tricyclic anti-depressants (i.e . ,

imipramine and desipramine) which produce anti-psychotic responses
similar to the phenothiazines and butyrophenones, are specific,

highly potent inhibitors of serotonin and norepinephrine re-uptake
(Wedley et al., 1978; Fuller and Wong, 1977).
Reserpine prevents the storage of biogenic amines in synaptic
vesicles and subsequently causes a virtual depletion in monoamine

concentration (Koelle, 1975) .

Monamine depletion occurs through an

increased monamine oxidase activity since the intracellular concentra-

tions of these neurotransmitters are initially increased on drug

exposure.

With time the amount of transmitter released into the

synaptic cleft after membrane depolarization is decreased and this
ultimately affects the degree of post-synaptic activation.

Reserpine

exposure in humans produces a state of indifference to environmental

stimuli and a tendency towards sleep.
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Benzodiazapines and related diazapams are t he most commonly
prescribed anti-anxiety drugs in us e t oday.

Animal behavior s tudies

have indicated that a lowering of ca te cholamine turnover is
res pon sible fo r the depressant action of t hese drugs while antianxie t y responses may be attributed to decreasing t he serotonin
turnover (Stein et al., 1975) .

Rastogi et al. (1979) determined that

ch ronic administration of diazepam to rats produced increased synapotosomal serotonin concentrations that were double the concentration
found in acute exposure.

Chronic exposure inc reased as well the

uptake a nd the rate of syn thesi s of sero tonin.

From their stud ie s

Rastogi et al. (1979) co nc luded that diazepam exerts its central
effects on mood and behavior by impairing the release of serotonin,
and to a lesser extent catecholamines.
From the drug literature it is understood that modulation of
synap t ic function is a useful means for producing behavioral responses.

In discussing these pharmacologically induced behavioral changes
Koelle (1975) pointed out that modification of synaptic activity
can be br ought about by us ing drugs that affect neurotransmitter
synthes i s , metabolism and turnover as well as the membrane release

and uptake mechanisms .

Additional modification can occur by

altering the synaptic membrane integrity, either increasing or
decreasing its fluidity or plasticity or by using drugs that
compe t e for post - synaptic membrane recepto rs t hus enhancing or
inhibiting the membrane response.

9

Norepinephrine and 5-Hydroxytryptamine (Serotonin)-Localization and Removal from the Synaptic Cleft
In a general discussion of the catecholamines, norepinephrine
(NE) and dopamine (DA), and the indolamine, 5-hydroxytryptamine
(5-HT), Synder (1976) pointed out that these biogenic amines are the
only putative neurotransmitters which have been localized in
discrete nerve tracts of t he brain and whose relationship with
specific animal or human behavior has been worked out.

Stereotaxic

mapping, utilizing a histochemical fluorescence method, reveals that
NE and 5-HT, although widely distribut ed in low concentrations
throughout the brain,

co ngregat~

in ce ll bodies to t he mutual

exclusion of the other (Un gersted t, 1971).

NE cell bodies are

extremely prominent in the locus coeruleus and give off both ascending
and descending bundles which reach all levels of the brain and spinal
cord.

Cell bodies containing 5-HT concentrate in the raphe nuclei

of the lower midbrain and upper pons.

The se rtoninergic axons

eminating from these nuclei ascend primarily into the forebrain from

which they then disperse to all areas of the brain.
Termination of the effects of NE and 5- HT , after release into
the synpatic cleft, occurs through a membrane transport phenomena
that returns these neurotransmitters back into the presynaptic
terminal.

This process, which is energy and temperature dependent,

ob eys Micahelis - Menten kinetics and is believed to be highly
specific for only one type of monoamine in any one terminal
(Iverson, 1971).

Na+ and K+, at physiological concentrations, are

required for op timum activity and it is believed that the divalent
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++ and Ca ++ as well have some function i n maintain ing this

cations Mg

activity at peak levels (White , 1975) .
Discovery of this re-uptake is c r edi ted to Axelrod and his
co-worker s (1965) , who found t hat radiolabelled, intravenously
injected, NE accumulated in tissues with dense sympathetic innervation.
Homogenization of this tissue and subsequent use of density gradients
revealed the label to be localized in the synaptic vesicles.

Later

work by Iverson and his coworkers (1967) revealed that the granular
storage process could be separated from the actual uptake into the
nerve terminals by using the drug resperine which enhances the release
of the monoamines from the storage vesicles but does not disrupt
membrane transport into t he terminal .

A carrier- mediat ed model for the transport of biogenic amines
across pre- and post-synaptic membranes and into glial cells has
been suggested by Hammerschlag and Roberts (1976).

In this model

the uptake process has an absolute Na+ requiremen t and ope r ates at

maximum velocity at physiologic Na+ concentrations.

Binding sites

for the transmitter exist in the synaptic membranes, are specific in

nature, and have an affinity with a Km of less than 1.0
monoamines.

~M

for t he

These amines bind much more readily in environments

with high Na+ concentrations (extracellular membrane surface) and
much less readily in low sodium environments (intracellular membrane
surface).

As the transmitter is rel ased into t he synapse during

neuronal activity, equilibration between receptor and transmitter

occurs because of the high Na+ concentrations in the synapse .

Under

this condition the transmitter readily binds to the receptor and in
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a process that is not yet understood but may depend upon various
asymmetries on the two sides of the membrane, such as oxidation-

reduction potentials, degree of phosphorylation and concentrations
of particular ions or metabolites, the transmitter is transported
through t he membrane into the intracellular compartment.

Since

intracellular Na+ concentration is low the transmitter rapidly
dissociates from the r eceptor and becomes available for mitochondrial
metabolism.

Thus it is suggested that the assymmetrical Na+

concentration sets up the conditions necessary for transport of
these transmitters.

Although metaboli ca lly generated ATP is not

directly required for this process there is an overall energy requirement for the transport to occur.

It is felt tha t the potential

energy of the Na+ gradient is probably the major sourc e of energy
for the carrier-mediated transport.

ATP is, of course, required for

operation of the Na+ pump (Na+, K+-ATPase) that maint ains the Na+
gradient .
§elected Aspects of Organophosphate
Neurotoxicity

Acute toxicity of o r ganophosphates is a product of t he specific
inhibition of ace t ylcholinesterase with the resutling accentuation
of cholinergic activity.

Although this esterase

inhibition is the

most acute effect, other enzyme inhibitions are known that are

unrelated to the cholinesterase inhibition.
treated rats with 3.2 mg/kg DFP (1.3 x LD

50

Jovic et al. (1971)
), after atropine pre-

treatment, and demonstrated a significant reduction in the succinate
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dehydrogenase, aldolase and Na+, K+-ATPase activities in brain slices.
Qualitatively similar effects were also detected in vitro.

Although

the study was performed utilizing a lethal dose of DFP it none the
less implicated this compound and possibly other structurally related
organophosphates as inhibitors of cellular metabolism.
For sometime it has been known that organophosphates produce
peripheral delayed neuropathies resulting in axo nal degeneration and
paralysis of affected limbs (Smith et al. 1930).

Initially the

foci a t which the organophosphates initiated this response was though t
to be the neuronal perikarya followed by retrograde axonal degeneration resulting frofu interference with somal metabolic functions
(Cavanagh, 1964).

Since then modern techniques have demonstrated

this hypothesis to be inaccurate.

Bouldin and Cavanagh (1979) have

presented evidence that the initial leasion commencing axonal
degeneration occurs within the axon itself.

Utilizing a teased nerve

fiber technique they were able to determine that the point of origin
ofthe neuropathy was in the distal, but non- terminal, segment of
the longest and largest nerve fibers.

Subsequent to the initial

lesion the axonal degeneration spread in a somatofugal direction to
involve the entire distal axon .

Prior to this degeneration fiber

varicosities and demyelinated segments were identified.
In support of Bouldin and Cavanagh's (1979) evidence for an
initial axonal lesion preceeding the axonal degeneration is a study
by Howland et al . (1980) .

The authors used a technique that allowed

them to produce a mononeuropathy involving only one hind limb.
By injecting radiolabelled DFP (2 mg / kg) into the left femoral
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artery of a cat and sectioning t he sciatic nerve in both the treateD
and contralateral sides, as well as spinal gangalia and dorsal and
ventral roots, one and twenty-four hours post treatment, they were

able to determine that DFP was restricted to the injected leg with
very little migration of label to the contralateral side or into the
r oots or ganglia.

The authors feel that if the perikarya were

involved in the genesis of this mononeuropathy it would be manifested
on both sides and significant levels of DFP would have been detected
in the somal preparations.
In a study of the functional capacity of motor nerve terminals
during DFP induced neuropathies Lowndes and Baker (1978) detected
a decrease in the ability of soleus alpha terminals to generate
stimulus-bound repetition.

21 days post exposure.

This depressed activity reached a maximum

Histologically the motor nerve t erminal

underwent marked degenerative changes but it appeared not to effect
the conduction velocity or single impulse transmission, both of which

were normal.

At this point the animal demonstrated a high-fast

step gait in the neuropathic limbs while the primary spindle
frequency of firing at various lengths of stretch was decreased.
The above studies, for the most part, were concerned with the

cholinergic parts of the nervous system.

They provided evidence

that DFP was capable of inducing degenerative changes in the nerve
fibers after exposure to a concentration of DFP greater than t hat
normally considered lethal.

Little information is available on the

affects produced after low level chronic exposure.

Since DFP and

other organophosphates are known to carry out membrane phosphorylation
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(Johnson, 1969) and also since Jovic et al. (1971) reported the
ability of DFP to inhibit CNS metabolic functions after in vivo
treatment, it would be of interest to assess the membrane effects
occurring within the CNS after organophosphate exposure.

Of

particular interest wo uld be the effects phosphorylation might have
on synaptic transmission and other synaptic membrane function.
Selected Aspects of Heavy
Metal Neurotoxicity
Pathological changes within the nervous system, biochemical,
functional and morphological, are documented expressions of heavy
met a l poisoning, of which lead and mercury have been the most
intensely studied (Hrdina et al., 1976; Pentschew, 1965; Smith,
1976) .

Arsenic and cadmium exposure is also known to initiate

neuropathology in experimental animals (Gabbiani et al., 1967;
Hrdina et al., 1976; Krigman, 1978; Rastogi et al., 1977; Sato et
al., 1978) but

~uch

less is know about their mechanisms of action .

In the studies mentioned, as well as others, it is generally
accepted tha t as a group heavy metals are able to effect both the
peripheral

and central nervous systems.

Some of these metals are

capable of injuring both systems while others are specific for one
or the other.

The critical factor in determining the type of

injury is t he solubility and distribution of a particular metal in
the body.

The type of injury produced is similar in both systems.
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Oehme (1978) felt that in general terms the toxicity of heavy
metals is principally a consequence of their high affinity for
many ligands such as proteins and amino acids.

Metal complexes are

readily formed with sulfhydryl groups and to lesser degrees with
amino, phosphate, carboxylate, imidazole and hydroxyl radicals of
biologically significant compounds, often resulting in protein
degeneration.

With the high affinity many metals have for protein

constituents and the significant role proteins have in membrane
structure and function it is to be anticipated that membrane barriers

might sustain considerable damage after heavy metal exposure.
In a review of the toxic effects of mercury, Chang (1977) stated
that the neuropathology is a consequence of membrane degeneration
followed by metabolic dysfunction that leads to functional changes
in the neurophysiology of neuron and axon.

This scenario is supported

by information showing subcellular accumulation of mercury occurring

in membrane fractions when characterizing the subcellular distribution

by ultracentrifugation (Yoshino et al., 1966a).

More recently

electron-microscopic histochemical methods (metal-sulfide coupling)
were able to demonstrate visually the close associations of mercury
with membranous structures and the increasing amounts detected in

the matrix of the cytoplasm and axoplasm as the intoxication
progressed (Chang and Hartman, 1972a). Surprisingly this study
indicated that very little mercury penetrates through the nuclear
membrane.

It has been known for some time that mercury inhibits protein
synthesis prior to development of neurologic symptoms while oxygen
consumption, aerobic and anaerobic glycolysis and sulfhydryl enzyme
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activities remain unchanged (Yoshino et al., 1966b).

It subsequently

was found that many enzyme activities were altered after mercury
intoxication and the onset of neurologic symptoms.

Succinic

dehydrogenase , ATPase and alkaline phosphatese activities decreased
indicating damage to mitochrondia, cell membranes and the blood-brain
barrier by mercury.

Paterson and Usher (1971) detected a decrease

in the ATP/ADP and ATP/AMP ratios as well as inhibition of

enz}~es

towards the end of the glycolytic chain in mercury treated rats.
Salvaterra et al. (1973) extended these metabolic studies and found
changes in phosphocreatine and adenosine nucleotides as well as
glycolytic intermediates.

RNA synthesis is also altered after

mercury intoxication but conflicting results have been obtained
indicating that increased or decreased sys thesis may be dependent
on the susceptibility of specific cell types (Brubaker et al., 1973;
Chang and Hartman, 1972a,b).

Somjen et al. (1973) reported that the

intracellularly recorded spike potential of many sensory ganglion
neurons of mercury poisoned r ats was significan tly prolonged,
indicating a retardation in membrane repolatization.

These au t hors

also indicated that t he primary site of damage is the cell bodies of
the sensory ganglion cells followed by axonal degenera tion and that
the largest myelinated fibers were affected to a greater extent than
the smaller fibers.
Human sensitivity to cadmium induced neurotoxicity is so poorly

documented that Kr igman (1978) stated that neurotoxicity is not a
feature of cadmium poisoning in humans.

Howeve r, Vo robj eva (1957)

examined 160 facto r y workers and reported CNS symptoms that included
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headache , vertigo , and sleep disturbances.

In 1961, Adams and

Crabt r ee indicated t hat anosmia (loss of the sense of smell) occurs
in humans exposed to heavy dust environments in alkaline battery
factories.

In laboratory animals there is evidence of cadmium initiating
neurolog i ca l disturbances.
cutaneous injection of CdC1

Gabbiani et a l. (1967) gave one sub2

to rats and rabbits a t various t ime

intervals after birth and found that lesions were detected in the
nervous system only in animals t reated at a very young age , mature
animals appeared t o be insensitive to th e cadmium trea tment .

Parenteral administ r ation of cadmium, at a low dose (10 ppm) t o ra t s
5-6 weeks old with a gradual increase in treatment until the maximum
dose (40 ppm) was reached at 14 months of age and maintained at
this level for an additional 17 months , was found to produce sligh t
leg weakness (Sato, 1975).

Pathological changes were detected in

the spinal peripheral nerves while being absent from the central
nervous system.

An additional study (Sato et al., 1978) that included

the same treat ment regimen and utilized electron microscopy revealed

segmental demyelina tion in the sciatic nerve beginning a t t he nodes
of Ranvier with active autophagocytosis of Schwann cells containing
myelin remnant s and dense bodies.

Rastogi et al . (1977) examined

t he effects of cadmium adminis te red to rats for 30 days, with
exposure starting at birth, and detected an increase in tryosine
hydroxylase and tryp tophan hydro xy lase activities in specific brain
re gi ons .

At t he low dose endogenous level s of NE , DA, and 5- HT

failed to change in the va r ious brain regions examined and the authors
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suggested that the increase in synthesis of the neurotransmitters
possibly led

to an increased utilization of these compounds that

produced the symptomatic effects.

At ·the high dosage level a

slight increase in turnover of the brain amines was noted as well
as an enhancement of the DA and NE levels in several brain regions.
The authors felt that their study indicated that cadmium acts at
some point in the metabolism of the biogenic amines to increase
intracellular synthesis and turnover.

In contrast with this

information Hrdina et al. (1976) found that cadmium exposure for
45 days at 1 . 0 mg/kg/day significantly decreased 5-HT concentration
in the brain stem of treated rats as well as induced a transient
enhancement of striatal DA levels.

Of special significance was the

finding that the 5- HT decrease persisted even after a 28-day
withdrawl from treatment.

All biochemical changes were noted prior

to the onset of overt neurotoxi c symptoms.

Although the studies of Rastogi et al. (1977) and Hrdina et al .
(1976) have qualitative differences in the manner that cadmium
effects the neurotransmitter levels, both studies provide evidence
for cadmium affecting the nervous system under appropriate conditions.

Whichever effect turns out to be correct or if both can actually
be produced but under different conditions, it must be realized
that the neurotransmitter system is of critical importance for
no rmal nervous function.
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Selected Aspects of Acrylamide
Neurotoxi c ity

Exposure of experimental animals to acrylamide results in the
development of delayed neuropathic lesions of the peripheral nervous
system (Fullerton and Barnes, 1966; Prineas, 1969; Tilson and Cabe,
1979).

As in other delayed neuropathies, acrylami de toxicity produces

a dying-back syndrome in which the lesion ascends the nerve tract
in a centripetal direction on continual exposure to the toxicant

(Cavanagh , 1964).

However, in acrylamide neurotoxicity the axonal

l esions are multifocal in nature and are not restr i!cted to the

terminal of the longest and largest axons as is seen in other delayed
neuropathies (Jennekens et al., 1979; Schaumberg et al., 1974).
In the histological examination of neuromuscular junctions after

acrylamide exposure, Tsujihata et al. (1974) observed the disappearance
of some axonal terminals from the pre-synaptic regions but the
preservation of other terminals within the same endplate region.

Extending this work Jennekins et al. (1979) attempted to correlate
morphological changes at the terminal arborizations of the neuromuscular junction with behavioral changes in rats, as exemplified by
ataxia and hindlimb paralysis.

Although multifocal swellings were

observed in the muscle groups examined, there was no correlation

between the frequency of these focal swellings and the behavioral
changes.

To account for this the authors speculated that other

factors such as the involvement of pre-terminal motor axons, peri-

pheral sensory neurons and the central neurons may be of equal
importance for t he development of c linical signs of acrylamide
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neuropathy.

They also felt that differences in the stages of various

lesions were not due so much to the time of the initial insult as

to the rate of r epair at any one site.

This is in agreemen t with

Spence r and Schaumberg's (1977) theory that acrylamide induced
distal axonal degenerat ion is the result of 1) failure of the
synthetic machinery in t he neuronal cell bodies, 2) impaired axonal
transport , and/or 3) direct compromise of metabolic processes in
the axons.

Additional information is becoming available to support this
theory.

Protein synthesis, as assessed by the rate of leucine

incorporation, is known to be inhibited in the nervous system

(Schotman et al., 1977a) although a causal relationship was not
demonstrated (Schotman et al . , 1977b, 1978) .

Bradley and Williams

(1973) were among the first to demonstrate acrylamide inhibition
of fast axonal flow in cats with acrylamide induced neuropathies .
Although no supportive information has been found, Schoental and
Cavanagh (1977) proposed tha t toxic substances such as acrylamide
might gain entrance to. the nerve fibers at the axonal terminals
or the nodes of Ranvier and inactivate enzymes or o t her cofactors

involved in axonal metabolism.

If the speculated binding to

enzymes or cofactors was to occur the resupply would be least
adequate at points distal to such lesions.
Since any effects occurring in the axon or the neuronal cell
body would ultimately be expressed in the nerve terminal it is
possible that an examination of normal functions in the terminal
might give an indication of the level of acrylamide exposure.
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Selected Aspects of Cyclodiene
Insectic ide Neurotoxicity
Cyclodine insecticides, the group to which Kepone belongs, are
often considered t o possess less acute toxicity but greater potential
for chronic toxicity than the organophosphates and carbamates (Allen
et al., 1979).

Principle symptoms of acu t e poisoning are

g~nerally

characteristic of central nervous system effects; hyperexcitability,
tremors and convulsions, with the convulsion usually but not always

preceeding o t her signs of toxicity (Wooley, 1976; Allen et al., 1979).
Attempts have been made to correlate behavioral changes, produced
after cyclodiene exposure, with concurrent changes in the levels of
biogenic amines (McGeer, 1971).

Sharma (1973) and Sharma et al.

(1976) reported that dieldrin reduced levels of NE, DA, and 5-HT in
mallard ducks at the same time that changes in aggressive and
confrontation

behavior were observed.

Other studies have indicated

a speCies difference in the reduction of brain amine concentrations·,

principally catecholamines; positive effects were seen in rats after

a-chlordane exposure (Hrdina et al., 1974) while the levels of the
biogenic amines were unchanged in mice after dieldrin treatment

although 5 -hydroxyindolae~etic acid (5-HIAA) , a 5-HT metabolite,
was increased sugges ting an effect on 5-HIAA efflux from the brain
(Sharma, 1976).

At present there is too little information available

to speculate whether an alteration in biogenic amine levels after
treatment with cyclodiene insecticides has a causal relationship
to the primary CNS lesion.
In spite of the well documented neurological signs observed in
cyclodiene poisoning histological alterations in the CNS are relatively
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slight o r non-existent (Hodge e t al ., 1967) .

At t he same time the

cyclodienes are known t o affect the conduction of the action
potential withou t altering the resting membrane potential of the
nerve fiber (Wooley, 1976).

Together t hese studies suggest tha t the

cyclodienes might produce a functional modification of normal synaptic
activity leading to the expression of the neurological symptoms .

To

date ver y little information is available in the literature examining
such a hypo t hesis .
Recently though, Kepone has been shown to stimulate the release
of neur otransmi tters from synaptosomes by preven t ing Ca++ sequestration in mitochond ria which normally would lead to reestablishment of the
resting membrane potential (En~ et al . , i979a).

End et al. (1979b)

also re po rt ed that Kepone and KCN stimulated rat synaptosomal Ca++
efflux by releasing mitochrondrial stores .

While KCN efflux

proceeded via Na+-Ca++ exchange across the plasma membrane Kepone
release of Ca++ was independent of the Na+-Ca++ or Ca++- Ca++
channels suggesting that a direct membrane perturbation initiates
this release.

To support t h i s hypothesis the study also found that

Kepone releases synaptosomal lacta te dehydrogenase as does KCN,
electron microscopic examination of these synaptosomal preparations

show the Kepone exposed sampl es undergoing membrane lysis while the
KCN treated preparations incurring only minor swelling.
In an examination of the transport processes leading to
inactivation of the bi ogenic amines released into the synapse,Ho
et al. ( 1980) report a decrease in dopamine and norepinephrine uptake
into mouse brain synaptosomes exposed to Kepone in vivo or in vitro .
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Kepone was shown to decrease the affinity of DA for the ligand as
well as the maximum amount of DA bound in b;th in vivo and in vitro

---

treated preparations.

----

The effect on NE was the same as DA in vitro

----

but the NE affinity in vivo was not significantly different from
the controls although the total uptake was reduced.
The above information indicates that at least one of the
cyclodiene insecticides is capable of modulating synaptic function,
although additional work is necessary to determine the relationship
of this effect to the clinical symptoms.
Metabolic and Functional Characterization
of Synaptosomes
Synaptosomes are synaptic terminals which have been sheared,
during fractionation, from their axonal connections and surrounding

glial cells.

After separation from the axon the terminal reseals

forming an intact structural unit (Jones, 1975).

Often the inter-

synaptic cleft and post-synaptic processes are isolated as a portion
of the unit.

Gray and Whittaker (1962) utilizing differential and

density-gradient centrifugation were the first to isolate and
identify synaptosomes. Synaptosomes sediment with mitochondria and
because of their size were overlooked during early sucellular fraction
studies on brain tissues.

Since the discovery of synaptosomes a considerable effort has gone
into the elucidation and characterization of the biochemical mechanisms
retained after separation.

Johnson and Whittaker (1963) showed that

synaptosomes contain a significant portion of the lactate dehydrogenase
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and potassium of the tissue homogenates.

This suggested that the

synaptic terminal resealed after shearing and loss of soluble
cons tituents was limited.

Bradford (1969) incubated synaptosomes

in vitro in appropriate media and demonstrated normal respiratory
function .

With glucose and pyruvate as substrates a high resp ira t ory

activity was seen.

On exposure to hypotonic solution respiration

diminished and became non- linear.

ATP and phosphocreatine were

synthesized with glucose as substrate.

Synaptosomes showed an active

accumulation of potassium from the media .

In a comparison of rat

synaptosomes and brain slices Bradford and Thomas (1969) showed that
both preparations were able to carry out similar metabolic functions .
Glucose was conver ted to lactate, aspartate, glutamate, glutamine,

alanine, and t-amino butyric acid (GABA).
amino

~cids

Pool sizes of these

were greater in cortex slices than in synaptosomes while

leakage of the amino acids from synaptosomes into the media was not
seen providing additional evidence for the intactness of the
membrane .

To qualify synaptosomes as models suitable for the study of
neurotranmission it is necessary to demonstrate the existence of
a trans - membrane potential.

Due to their small size, 0 . 5

~m ,

direct

measurement of membrane potential is difficult and it becomes
necessary to establish its existence by inference.

Application of

electrical pulses to synaptosomal preparations gives rise to

+

increased me tabolic rates, loss of K and differential loss of
physiologically active amino acids (Bradford et al., 1973).

This
+
same study also showed t he loss of synaptosomal K and amino acids on
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+

exposure to depolarizing concentrations of K .

An active acc umula-

tion or extrusion of various ions supports the existence of a

trans - membrane potential .

Ling and Abdel- Latif (1968) demonst r ated

the active removal of Na+ from synaptosomes while K+ (Bradford,
1969) and Ca++ (Lust and Robinson, 1968) are actively accumulated .
Whi t take.r (1969) in anticipa t ion of the evidence revealing
synaptosomes to be metabolically functional and to have physiologically
active memb r ane activity described synaptosomes as "minature nonnucleated cells" .

Investigations of neurotransmitter release and

uptake add support for this concept .
Electrical stimulation and depolarizing K+ concentrations were
shown to be responsible for the release of acetylcholine from
synaptosomal suspensions (Haga, 1971).

DeBelleroche and Bradford

(1972) utilized s ynap t osomal beds (deposits of the ner ve endings
between nylon gauze to r educe t issue:fluid ratios) to support the
evidence for acetylcholine release and found that this release was
enhanced following electrical or K+ stimulation .

In Ca++- free media

acetylocholine released in t o the incubation medium was reduced.
Ca++-dependent norepinephrine loss from synaptosome to the medium
was also observed on electrical or K+ induced depolarization
(Blaustein et al . , 1972).
Membrane a c tive transport processes have been demonstrated for
cations, amino acids and biogenic amines ,

Kurokowa et al. (1965)

in one of the first studies on synaptosomes, examined the Na+, K+dependent adenosinetriphosphatase

activity of the membrane .

showed guinea pig synaptosomes accumulated K+ and extruded Na+

They
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against concentration gradients .

Oubain and p-chloromercuri-

benzoate inhibited this enzyme function in a manner quantitatively
similar to that seen in other tissues .

L-Glutamate and GABA

exhibited net upake in depolarized synaptosomal fractions that are
Na+ and temperature dependent (Roskoski, 1978) .

Depolarazing media

was used for the assay to reduce the homoexchange of synaptosomal
and exogenous L- glutamate or GABA .

Depolarization of synaptosome

preparations with KCl was shown to accelerate choline uptake over
the control rates (Roskoski , 1977).

The neurotransmitter biogenic

amines undergo active uptake after release from synaptosomes.

Garey

and Heath (1974) prepared synaptosomesfrom post - mortem human brain
tissue, 4- 8 hours after death, and measured the levels of catecholamine uptake .

Active uptake was seen in all samples .

comparison , synap t osomes prepared from rats,

For

l or 12 hours after

sacrifice, demonstrated active uptake at both time intervals.
Kuhar et al. (1972) examined the transport of serotonin, dopamine and
norepinepherine in rats with a nd without Raphe lesions.

In all cases

active accumulation was seen wit h serotonin being the only trans-

mitter to have an altered uptake in treated animals.
Utilization of synaptosomes as a model for the investigation of
neurotransmission has several advantages.

First, the integrity of the

membrane and demonstration of its functional capacity is comparable
to the in situ condition at the synapse.

Secondly, the characteri-

zation of their metabolic activity indicates that all enzymes and
co- factors are presen t as would be seen in situ .

Thirdly, the

studies showing the viability of synaptosomes for several hours after
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removal from the brain allows for time related studies .

A final

advan t age would be the characterization of synaptic activity away
from the diluting factors seen with tissue homogenates .
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MATERIALS AND .METHODS
Animals
Simonsen derived Sprague-Dawle y male rats, 150-300 grams
(Simonsen Labo ratories, Inc., Gilroy, CA) were used for all
synaptosomal preparations .

Housing conditions consisted of a 12-

hour day-night cycle and five animals pe r cage with food and water

Chemicals
Ficoll for the discontinuous gradient was obtained from
Pharmacia (Uppsala, Sweden).

The following chemicals were purchased

from Sigma Chemical Company (St. Louis, MO); albumin recrys tallized
fr om Bovine serum, 3-0-met hyl fluorescein, 3-0-methyl fluorescein
phosphate, S-Nicotinamide adenine dinucleotide, reduced form (NADH),
and ouabain.

Chlorpromazine was obtained from Smi th, Kline, and

French Labs. (Philadelphia , PA).

Sources, purity, and chemical

names for all test compo un ds are listed in Table 1.

De-ionized water

was used for all procedures that required water as a diluent.
The radio-labelled amines were purchased from New England
Nuclear Corporation (Boston, MA) and were supplied with the following
3
specific activities, 5-1,2- H(N)-Hydroxytryptamine creatinine
3
sulfate, 29.6 Ci/mmol and DL-7- H(N)-Norepinephrine, 15.2 Ci/mmol.

Table 1.

Test compounds used for synaptosomal uptake and K+-dependent phosphatase studies .

Compounds

Chemical Name

Source

Grade

or Structure

Hethyl mercuric c hloride

CH HgCl
3

Alfa Division

95+% pure

Mercuric nitrate

Hg(N0 )
3 2

Fisher Scientific Co.
Fair Lawn, NJ

Reagent grade

Cadmium chloride

CdC1

J, T. Baker Chemical Co.
Phillipsburg, NJ

Reagent grade

Kepone

decachlorooctahydro-1,3,
4,-metheno-2H-cyclobuta
(cd}-pentalen-2-one

U.S. Environmental
88% pure
Protection Agency,
Toxicology Division
Research Triangle Park, NC

Ac rylamide

CH =CHCONH
2

Eastman Kodak Co.

phosphorofluoridic acid
bis(l-methylethyl) ester

Sigma 'Chemical Co.
St, Lo uis, MO

Analytical grade

diethyl-p-nitrophenyl
ester phosphoric acid

American Cyanamid Co.
Agricultural Division
Princeton , NJ

Practical grade

Diisopropyl fluorophosphate
(DFP)

Paraoxon

2

Reagent grade

Rochester, NY

N

<0
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Preparation of "Modified Crude Mitochondrial"
Fraction (MCM)
The preparation of synaptosomes followed the procedure of
Cahill and Medzihradsky (1976) with the addition of a few modifications to increase the yield of synaptosomal fraction.

procedures were carried out at 0-40C in an ice- bath.

All tissue

Five rat brains

were remove d and placed in ice - cold 0 . 32 M sucrose, immediately after
sac rific e.

Cerebral co rtices were dissected free from the whole brain,

combined, weighed, minced, and homogenized in 0.32 M sucrose at a
concen tration of 10 percent (w/v) in a 50 ml Potter-Elvehjem homogenizer equipped with a teflon pestle.

The homogenate was then

cen trifuged at 0- 4°C for 15 minutes at 3,000 x g, in an International
high speed refrigerated centrifuge model HR- 1 equipped with a fixed
angle rotor, to remove blood, nuclei and cell debris.

The resulting

supernatant was cetrifuged at 15,000 x g for 25 minutes and subsequen tl y divided into three fractio ns.

Fraction 1, supernatant;

fraction 2, upper portion of pellet characterized by a white layer
having the appearnce of a ring or "halo" on top of fraction 3, a

firm yellow pe l let.

Fraction 2 and 3 when combined represented the

crude mitochondrial

fraction that contained mitochondria, synaptosomes

and myelin fragments .

Fraction 1 was remo ved with a pasteur pipet and

saved , fraction 2 was also extracted and represent s a modified crude

mitochondrial fraction (MCM) enriched in synaptosomes (Cahill and
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Medzihradsky , 1976), t his f r action was also save d.

Fraction 3 was

then dilut ed with 10 ml of 0.32 M sucrose and re-centrifuged along
with fr ac tion l and 2 at 15,000 x g for 25 minutes.

Supernatants

from all three fractions were then removed and discarded while the
''halo" that layered the pellet of fraction three was removed and
combined with the pellet of fraction two.

The comb ined fractions

wer e re-centrifuged at 15,000 x g for 25 minutes after which the
supe rnat ant was discarded and t he pellet was t hen combined wi t h the
pr evious pel let of fraction l which had been diluted with 0.32 M
sucrose (0 .5 ml /c erebral co rtex) .

This final MCM suspension was

t hen gently hand homogenized in a glass Dounce homogenizer in the
final step of the preparation.

In the procedures outlined by

Cahill and Medzihradsky (1976) only the "halo " of the initial
15,000 x g pellet was saved while the supernatant and the firm
yellow pellet were discarded.

By retaining these fracti ons t he

ultimate MCM y ield was increased indica ting a more nearly comple t e
re covery of synap to somes.

Total preparation time from r emoval of

brain to final MCM was 3 hours.

A flow diagram of the synaptosome

preparation is given in Illustrat ion l.
Density-Gradient Separation of Synaptosomes,
Mitochondria and Mye lin Fragments
Where it was necessary to separate the homogenate into puri f ied
f rac tions of synap t osomes, mitochondria and myelin a procedure
utilizing density-gradient centrifugation, was outlined by Kurokawa
et al. (1965) , was used.

After t issue homogenazation the homogena te

was prepared as indicated above, through the first 15 , 000 x g
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Homogenate
lOZ (Y/v) in 0.32 M sucrose

1,000 11g (U min)

Supe-rnatant

Pelltot
(discard)

I ...~ .. ,.....,

Resuspend in
10 ml 0.32 11

Supernatant

1101

Pdh:t

Pellet
supernatAnt
(dlsc:nrd)

15,000 J:g
(25 min)

15,000 11g
(25 min)

15,000 xg
(25 min)

reJ let

~upernnta nt

(dt11c:nrd)

combine
Pellet

15 , 000 Ill:
(25 111in)

Supernatant
(discard)

Resuspended in
0 .3 2 H (Oiucrose ,

0.5 ml /b rain

Supernntant
(dhcnrd)

Final

M01

Illustration 1.

Fl ow char t fo r isolation of MCM fraction from rat
cerebral cortices.
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centrifugation, at this point the entire pellet, crude mitochondrial
fraction (fraction 2 and 3), was diluted

with 0.32 M sucrose to a

concentration of 3 . 0 ml/gram of original tissue.

A 1.0 ml aliquot

of this suspension was then layered on a discontinuous densitygradient, consisting of 2.0 ml of 3 percent (w/ v) and 2.0 ml (w/ v)
Ficoll dissolved in 0.32 M sucrose, pre-chilled to 0-4°C.

The

gradients were then centrifuged at 20,900 x g for 15 minutes
(International B- 60 Ultracentrifuge with a #487 SB-283 titanium
swinging bucket rotor) resulting in the formation of three distinct
layers, A, B, and C.

The liquid phases of A and C were nearly

transparent, whereas that of B was hazy.

The interface between

layers A and B was white while that between B and C was greyishwhite and the pellet, in layer C, was brown.
Electron microscopic studies of Kurokawa et al . (1965) showed
A to consist mainly of fragments of myelin sheaths, also present
were a few small synaptosomes as well as other vesicular membrane
fragments.

Subfraction B was principally composed of synaptosomes

with a heterogenous mixture of membrane fragments as well as an
occasional mitochondria.

Subfraction C consisted mainly of mito-

chondria but an occasional synapt osome, as well as assorted membranous
fragments, were also found to be present.
To separate the three layers each was extracted with a pasteur
pipet and then centrifuged at 105,000 x g for 20 minutes.

The

supernatant was then discarded and the pellet resuspended in an
a ppropriate medium .
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Synaptosomal Assay for NE and 5-HT Uptake
Within 15 minutes of the final step of the MCM pr eparation the
as say for measu rement of NE or SHT uptake was started.

The MCM

fraction was kept at 0 . 32 M sucrose (0 - 4°C) until just prior to its
addition to the assay tubes.

The assay was performed in 15 ml

centrifuge tubes at 37°C with appropriate 0°C controls.

Except for

the actual incubation at 37°C all s t eps were carried out at 0- 4°C.
As was needed for the uptake studies, 0.05 ml of the MCM suspension
was transferred to 0 . 90 ml of assay buffer that included the compound
to be studied, if appropriate.

The assay buffer contained the

following final concentrations (mM):

Tris , 35; NaCl, 100; KCl,

10; Mgso ·7H o, 1.2; KH Po , 1.2; NaHC0 , 1.0; sucrose, 25; glucose ,
2
4
2 4
3
10; and ascorbic acid, 1.0; t he pH of the buffe r was adjusted to
7.4 with HCl.

To start the assay, 0 . 05 ml of a radiolabelled

compound, the activity of which was adjusted to 0.03-0 .10

~ Ci

per

0.05 ml, (the final specific activity was adjus ted by the addition
of non-labelled NE or SHT as needed), was added to the appropriate
tubes which were then incuba t ed at 37°C in a shaking water bath
for a predetermined length of time .

At the end of the incubation

time the samples were placed into the ice-bath and the radio-labelled
biogenic amine was then added to the 0°C controls and all samples
were centrifuged at 8,000 x g for 5- 7 minutes .

After pelleting the

synaptosomes the supernatant was removed and 1.0 ml of 0.4 N perchloric
acid was gently added to each sample to extract the radio -l abelled
compo und.

Af ter three hours duplicate 0.2 ml aliquots were prepared

for liquid scintillation counting in a Packard Tri-Carb 2660 liquid
scin tillation counter.
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Protein was determined by the method of Lowry et al. (1951)
for each group of samples using crystallaized bovine serum albumin
as the standard.
Assay for Lactate Dehydrogenase Activity
Synaptosomal lactate dehydrogenase (E .C . 1.1.1 .2 7) activity
was determined by the method of Bergmeyer and Bernt (1974) in which
the disappearance of NADH is monitored over time.

The assay was

carried out in a cuvette with a 1.0 em light path and monitored at
340 nm in a Perkin-Elmer, Coleman 124 doublebeam spectrophotometer.
The total volume for the assay solution was 3.15 ml and consisted
of t he following components and their final concentrations:

phosphate,

48 mM; pyruvate , 0.6 mM; NADH, 0.18 mM; and 0.1 - 0.3 mg MCM protein.
Tri t on X-1 00 (final concentration 0.1 percen t) was used t o determine
intra- synaptosomal LDH activity while the LDH activity in the
absence of Triton X-100 was considered to be extra- synaptosomal.
The change in E
was recorded every 60 seconds for 3.0 minutes
340
to obtain an average value in the presence or absence of Triton X-100.
Activities were calculated according to the following equation:

€

x d x mg prot./ml

~mo les

NADH disappearing/mg
prot./min

E
340

change in extinction at 340 nm

d

light path, 1 . 0 em
NADH extinction coefficient, 6.2

cm 2 /~mole
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K+-Dependent Phosphatase Assay
MCM was diluted with 250 mM Tris-HCl pH 7.4 to a concentration
of app roximately 0.1 mg/ml to give a final protein concentration
of 1.5-2. 0

~g/ml .

The 3-0- methylfluorescein phosphatase assay

developed by Huang and Askari (1975) was used to monitor K+-dependent
phospha tase (E.C . 3.6.1.3) activity and is based on t he determination
of t he amount of fluorescence due to the formation of 3-D-methylfluorescein.

Fluorescence measuremen ts were made with an Aminco-

Bowman spectrofluorometer.
1.0

~M

The standard assay medium contained

3-0-methylfluorescein phosphate, 1.0 mM MgCl , 10 mM KCl,
2

and 50 mM Tris-HCl pH 7.4 in a final volume of 3.0 ml.
meter was s tandardized wi th a 1. 0

~

The fluoro-

solution of 3- D- methyl-

fluorescein, to obtain a 50 percent fluorescence, in the same buffer
solution that was used for the assay.

The excitation and emission

wavelengths were 465 and 518 nm, respectively.

All assays were

carried out at 37°C by pumping water from a waterbath through the
cuvette chamber which was designed for such a circulating water
flow.

Blank readings were determined for 0.05-0 . 10 ml MCM in the

assay buffer without the substrate.

On addition of the 3-0-

methylfluorescein phosphate the change in fluo resc ence .was monitored
on a strip chart recorder for two minutes.

The change in fluorescence

per time period was calculated and used in t he following equation
to de termine the activity of the phosphatase:
1
60
50 x prot. x time
dX

nmoles phosphate liberated/mg prot . /ho ur
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dX

change in fluorescence reading for a specified time period

50

emi ssion of standard ( l

~M

3-0-methylfluorescein)

prot.

final concentration of protein in mg/ml

time

length of reaction in minutes
Est i mation and Statistical Treatment
of K and V
Values
m
max

Km and Vmax constants were calculated according to th e method
of Wilkinson (1961) which incorporates t he determination of the
statistical parameters from the experimental data.

38

RESULTS

The objective of this s.tudy "(as to determine the iniluence
various environmental pollutants have on synaptosomal inactivation

of norepinephrine (_NE) and 5-hydroxytryptamine ( 5-HT ).

In order to

accomplish this it was necessary to characterize the kinetics of the
transport process as well as to determine the optimum conditions fo r
such a characterization.

Chlorpromazine and ouabain were used as

positive inhib itor s of the uptake process to help determine the
suitability of the synaptosomal preparations used in this study.
A K+-dependent phosphatase was also monitored in the synaptosomal
membrane to determine the effec ts the test chemicals have on the
Na+, K+ gradient which is required for optimum transport of NE
and 5-HT.
Characterization of NE and 5-HT Uptake

Uptake versus protein concentration

Since this study required the preparation of numerous MCM
fractions it was necessary to determine if the NE and 5-HT uptake
processes possessed a linear relationship over the range of protein

concentrations used.

Figures 1 and 2 indicated that such a relation-

ship existed and that the uptake process had an initial linearit y
which was lost at higher protein concentration.

All uptake studies

were performed within the demonstrated range of linearity.
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Figure 1.

Representative presentation of the relationship between NE uptake into MCM
fraction and MCM protein'concentration. The uptake assay was performed with
0 . 5 ~M NE at 370C for 5.0 min .
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Figure 2.

Representative presentation of the relationship between 5HT uptake into MCM fraction
and MCM protein concentration . The uptake assay was performed with 0.1 ~M 5HT
at 37°C for 3.0 min .
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Uptake versus time

In assessing the optimum condition for the up t ake s t udy it was
necessary to determine the time dependency of the transport
processes in the MCM preparations .

The specific activity of the

NE up t ake reached a maximum at 10 minutes while the 5-HT uptake
reached its peak value at 4 minu t es (Figure 3).

NE uptake increased

curve - linearly for the firs t 5 minutes at which time the linearity
decreased and a plateauing occurred between 10 and 15 minutes
5-HT uptake also had an early linear relationship between l and 4
minutes but by 5 minues a decline in total uptake was observed.
Since a time dependency existed for these two uptake systems the
subsequent experiments were performed wi thin the linear segment.
With NE a 5 minute assay time was used while 3 minutes was used

for the 5-HT assay.

TI1ese time periods were used throughout the

remainder of the study.
Estimation of kinetic constants

The transport of biogenic amines into the pre-synaptic terminal

is an active process with identifiable kinetic constants.

Table

2 lists the K and V
values as determined for NE and 5- HT in the
m
~x
MCM preparations .

5- HT uptake was shown to have two transport

processes while only one such process was identified for NE.
The biphasic nature of the 5-HT uptake is readily evident in
Figures 4 and 5.

Figure 4 is a standard plot of substrate

concentra t ion (5-HT) versus velocity (pmoles 5- HT/mg protein/min)
and can be interpreted as showing the two phases of the 5- HT
transport with the high affinity process occurring at concentrations
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Table 2.

Kro and Vmax yalues for the 5HT and NE uptake into the
MCM fraction . a,d
5HT
high affinity

Kb
m

vmax

0.40 ± 0 . 16
c

2 . 54 ± 0. 77

NE
low affinity
3 . 64
10.0

1.11 ± 0.26
4.65 ± 0.47

aKm and Vmax values determined by the method of Wilkinson (1961)

buM
cpmoles / mg protein/min
dEach value represents the mean± s. d. ob taine.d fr om 2 - 4 de t erminations involving 2 - 4 synaptosomal preparations except 5HT low
affini t y
Kro and Vmax value s which were obtained from only one
MCM preparation.
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Time dependence of biogeni c amine uptake into MCM fraction. The data presented
for NE (0----0) and SHT (t----1) are representative experiments performed with
0.5 ~M NE and 0 . 1 ~M SHT.
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Standard substrate vs velocity plot for 3H-5HT uptake
into a MCM fraction . The data points indicate the
presence of two transport processes, Km and Vmax values
obtained for both processes are presented in Table 2.
Each point is the mean of 2-4 determinations involving
2-4 separate MCM preparations. Assay performed in
duplicate at 37°C for J . Q. min with simultaneous 0°C
con t rols.
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Lineweaver-Burk plot of the uptake dat a for 3H-5HT
presented in Figure 4. The obtained Km and Vmax values
are presented in Table 2. Crossbars designate the S.E.M .
of the data collected from 2- 4 MCM preparations. Circles
without bars repres ent individual observations.
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below 0.25

~M

and the low affinity uptake operating above 5-HT

concentrations of 0.5

~M.

Using a Lineweaver-Burk reciprocal

plot of 1/v versus 1/S (Figure 5) a mo re accurate estimation of
the Km and Vmax was obtained.

With this approach the Km and Vmax

for the high affinity uptake were ·calcula ted as 0.45
pmoles/mg protein/min, re s pe c tively .
was determined to have a Km of 3.64
protein/min.

~M

and 2.86

The low affinity uptake
~M

and a Vmax of 10 pmoles/mg

The distinction between these two processes is

evident with the inter section of the two lines in Figure 5.
NE concentra ti ons ranging f r om 0.05 -1 0

~M

were used t o ob t ain

the information that is graphically presented in Figures 6 and 7.
A smooth perpendicular right-handed hyperola is obtained in Figure 6
in a plo t of substrate concentration ve rsus velocity a nd suggests
that first-order kinetics are approp ri a t e at low s ubstrate (NE)
concentrations.

By replotting this data on a reciprocal plot of

1/v verus 1/S (Figure 7) the

~

and Vmax we r e identified as 1.11

and 4.65 pmoles NE/mg pro t ein/min, respectively .

~M

A single set of

kine tic con stan ts were obtained indicating the existence of only
one uptake process for NE in synaptosomes.
The concentrations of 5-HT and NE used fo r the majority of
t his s t udy were based on the Km values described above.
0.1

~M

was the con centration chosen while 0.5

~M

For 5-HT

was used for all

experimen ts involving NE uptake .
Localization of NE after incubation
in MCM preparations
MCM preparations were enriched in synaptosomes but con t ained,
to a lesser extent , mitochondr ia and various types of membrane

47

4
c

E

'

3

2Q
~

E

'ru

2

~

0

E
Q

1

2

4

6

8

10

NE. (uM)

Figure 6.

Standard subs trat e vs velocity plot for accumulation
of 3H- NE a t various conc entrations into MCM fractions.
Each point represents the mean of 2-4 determinations
involving 2-4 different MCM preparations. Assays
performed in duplicate at 370C for 5.0 min with
simultaneous 0°C co ntrols.
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Lineweaver-Burk plot of the uptake of 3H-NE by the MCM
fraction. The data presented is a re-plot of the
information presented in Figure 6. The obtained Km and
Vmax values are presented in Table 2. Crossbars
designate the S. E.M.

fragments (Cahill and Medzihradsky, 1976).

Several experiments

were performed to determine if the non-synaptosomal components were
competing with synaptosomes for the NE or 5-HT used in the uptake
studies.

In Table 3 the results of purifying the MCM preparation

after exposure to NE indicate that greater than 95 percent of the
NE retained in the preparation after assay was found in the synaptosome fraction (B).

Less than 5 percent was found in the mito-

chondrial fraction (C) while the myelin fraction (A) had no
measurable retention of the NE .

In this study the assay buffer was

without pargyline, a monoamine oxidase inhibitor, which would have
prevented rnitochrondrial metabolism of the NE.

However, in Table 4

the NE and 5-HT uptake was measured in the presence of pargyline.
In these experiments pargyline did not increase the biogenic amine
uptake into synaptosornes by inhibiting mitochondrial metabolism
of these compounds and thus increase amine concentrations available

to synaptosomes.

The information presented in Tables 3 and 4 indicat e

that the contaminating elements of the MCM preparations did not
interfere with synaptosomal uptake of NE or 5-HT .
Lactate Dehydrogenase Activity as a Normaiization

Factor Between MCM Preparations

Since many MCM preparations were used for this study it was
necessary to determine the degree of membrane intactness between
preparations in order to assess the feasibility of directly comparing
data from each preparat ion .

To accomplish this, lactate dehydrogenase

activity (LDH) was monitored in several preparations.

LDH measurements

50

Table 3.

Localization of

3

H-NE after uptake into a synapotosomal

preparation.
Gradient a
fraction
A

0°C

12moles NEb
37oc
Difference

0.02

NDd

ND

Composition

myelin and
various mem-

brane fragments
B

0.68

8.50

7.82

synatposomes

c

ND

0 . 34

0.34e

mitochondria

aUptake assay performed as described in methods after which MCM
pellet resuspended and layered on a 3 - 13% discontinuous ficollsucrose gradient.

bValues obtained were assayed at the indicated temperature and are
expressed as pmoles NE/rnl.
cComposition .determined by Kurokawa et al. (1965).
dND indicates radiolabel was not detected.
e4.5% of fraction B.
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Table 4.

Effect of pargyline on NE and SHT uptake into MCM
fraction.

Pargyline (M)

0

Amine Uptakea
pmoles/mg protein/min

SHT or NE

5HT (0.1

x

10- 6 M)

10-s

0.38

10- 4

0.46

0

NE (0 .5 x 10-

6

M)

10- 4
5

X

0.48

10- 4

aUptake determined in one MCM preparation.

3 . 08
2.38
0.58

were determined for the extra- and int ra- synaptosomal compartments.
Since synaptosomal concentrations varied between preparations the

monitoring of LDH activity in both compartments enabled batch
comparisons to be made by using the extra- to intra-synaptosomal
ratio (extra/intra) as an indicator of synaptosomal membrane
in t egrity.

In Table 5 the synaptosomal LDH ratio is less than 0 . 15

in ei ght of the nine preparations indicating a very intact and nonpermeable membrane.

The 5- HT uptake was determined in each of these

preparations and the information in Table 5 shows that thi s activity
is very similar in all preparations .

The correlation coefficient

obtained when comparing the LDH ratio t o the 5- HT uptake is 0 . 043 and
indicates t ha t such a correlation does not exist.
Chemical Influence on NE and 5- HT Uptake

Chlopromazine and ouabain were used as positive con trols for

validating the functionality of t he synaptosomal preparations .

Data

in Figure 8 indicates that chlo rpromazine inhibited the synap t osomal
uptake of NE and 5- HT.

The Ic

50

(the concentration of test chemical

t ha t inhibited the uptake by 50 percent) for bach processes were
similar with 50 percent inhibition of NE up t ake occu rring at
1 . 1 x 1010

-5

M.

5

M wh i le 5-HT uptake was inhibited by 50 percent at 3.2 x

Although the Ic

50

•s were nearly iden tical the shape of the

two curves were dissimilar.

In Figu r e 8 the NE process is below

control levels between 10- 6 - 10- 4 M chlo r promazine .

With 5- HT

uptake chlorproma zine was effec tive in a much narrower range 10- 6 - 10- 4
M and the slope of the line is much steeper than that seen with the
NE process .
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Table 5.

Corre l ation of 5HT uptake with the MCM Lactate
Dehydrogenase activity.

MCM Preparation

LDH ratio

a

5 HT uptake

l

0 . 285

0 .69

2

0.132

o. 72

3

0.146

0 . 91

4

0.124

0.69

5

0.101

0 . 70

6

0.059

0.69

0 . 092

0. 72

8

0.117

0. 75

9

0.123

0.059

0.131 ± 0. 063

0. 72 ± 0.08

Mean:

c

Corre lation coefficient:

0.043

aRatio of extra-synap to somal/intra-synaptosomal LDH activity,
determined spectrophotometrically by the measurement of the
conversion of NADH ~ NAD.
b5HT uptake determined using 0.1 uM 5HT for 3 min at 37°C,
activity expressed as pmoles 5HT/mg prot./min.
cMean ± s. d.
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Figure 8.

Chlorpr omazine inhibition of the NE (0----0) and 5-HT
( t----1) uptake int o the synap t osomal pr eparations.
Concentrations of the biogenic amines were NE, 0.5 JJM
and 5-HT, 0.1 JJM . Crossbars designate S.E.M. for data
from 3 MCM preparations, circles without bars represent
individual obs ervations. Ho rizontal dashed l i nes indicate
conf idence limits f or control values .
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Ouabain inhibition of the synaptosomal uptake processes was
positive only for NE uptake, the 5-HT uptake was not affected.

rc 50

The

-4 M with an effective
value for the NE transport was 1.1 x 10

4
3
range occurring between 0.5 x 10- -1.0 x 10- M (Figure 9).

The slope

obtained for NE uptake is a linear function of the ouabain concentration
over the range tested.

With the 5-HT uptake system control values

6
3
were obtained between 10- -10- m ouabain.
In testing the effects several heavy metals have on the synaptosomal tranport process i nforma tion presented in Figures 10 and 11
and in Table 6 indicate that the two mercurials, CH HgCl and Hg(N0 ) ,
3 2
3
inhibited both the NE and 5-HT process while CdC1
effect on either process.

2

had no significant

The alkyl mercury compound, CH HgCl,
3

appeared to inhibit both NE and 5-HT uptake in a similar manner, as
well as to a similar degree.

rc 50 •s

for the uptake processes were

NE, 1.1 x 10-4 M and 5-HT, 2.5 x 10-4 M.
is quite small.

The actual effective range

Hg(N0 ) , an inorganic mercurial, was not as
3 2

effective an inhibitor of the transport systems.

Although the

rc 50

obtained with Hg(N0 ) was within the same magnitude as the CH HgCl,
3
3 2
Hg(N0 ) did not completely inhibit synaptosomal transport of NE or
3 2
5-HT. At 10- 3 M, CH HgCl inhibition of the NE or 5-HT uptake was
3
complete while the Hg(N0 ) inhibition at the same concentration was
3 2
only 50-65 percent complete.
Kepone was capable of completely inhibiting both NE and 5-HT
uptake as is indicated in Figure 12.

rc 50

values were estimated

to be 9.4 x 10- 5 M for NE and 3.3 x 10-4 M for 5-HT.

The effective

inhibition range was small for both processes, NE inhibition occurred

between 0.5 x 10 - 4 -0.5 x 10- 3 M Kepone and 5-HT inhibition was less
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Figure 9.

Contrasting effects of ouabain on the biogenic amine
uptake into synaptosomes. NE (0----0) uptake was assayed
at 0.5 ~M NE while 5HT (t----1) uptake was determined
at 0.1 ~M SHT. Crossbars designate the S.E.M. for
experiments from 2-3 MCM preparations, circles without
bar represent individual observations. Horizontal
dashed lines indicate confidence limits for control
uptake.
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CH 1HgCl inhibition of synaptosomal biogenic amine
uptake. NE (0----0) and 5-HT (1----t) uptake were
followed using 0.5 uM and 0.1 uM 5-HT, respectively.
Crossbars are the S.E.M. for 2 MCM preparations while
horizontal dashed lines designate the confidence limits
for the control uptake. Circles without bars
represent individual observations.
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Hg(N03l2 influence on MCM NE (0----0) and SHT (t----1)
uptake . NE uptake was measured in the presence of
0 . 5 ~M NE while 0.1 ~M SHT was used for the SHT assay.
Crossbars designate S. E.H. for data collected from 2-3
MCM preparations, horizontal dashed lines indicate
confidence limits for the control uptake. Circles
without bars represent individual observations.
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Table 6.

Inhibitory influence of various environmental pollutants
on synaptosomal uptake of NE and 5-HT.

Chemical

CH HgCl
3

(M)

NE

10- 3
10- 4

26*

10-s

Hg(N0 )
3 2

CdC1

2

Kepone

Acrylamide

DFP

Paraoxon

*p <0 . 05
~on-detectable

%. Control U]1take

Concentration

10- 3

0*
115
35*

SHT
0*
100
103
47*

10- 4
10- 5

lOS

90

94

93

10- 3
10- 4

95

113

77

149

10- 5

94

106

10- 3

0*

10- 4
10- 5

49*
95

0*
86
112

10- 3
10- 4

88

70

90

87

10- 5

88

73

10- 3
10- 4

76

63

91

79

10- 5

94

71

10-J

115

85

10- 4
10- 5

113

90

84

97
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Figure 12.

Kepone inhibition of NE (0----0) and SHT (1---1)
synaptosomal uptake. 0.5 ~M NE and 0.1 ~ M SHT were
used for the assay . S. E.M. for the data collected in
2-3 MCM preparations is indicated by the crossbars
while the confidence limits for the control uptake is
designated by the horizontal dashed lines. Circles
without bars represent individual observations.
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4
3
than control levels in the 10- - 10- M range .

As was already shown

in Figures 10 and 11 for CH HgCl and Hg(N0 ) , respectively , the
3
3 2
slope within the effective inhibitory range for Kepone was also quite
steep.
Table 6 lists several other chemicals that were tested for their
ability t o inh i bit the synaptosomal transport processes.

Acrylamide ,

DFP, and paraoxon were unable to produce a significant inhibition
of either the NE or 5- HT uptake .

Although acrylamide and DFP did

inhibit the process 30-40 percent at the highest concentrations
tes t ed , 10-

3

M, this was no t i nterp r eted as being significan t ly

different from the control values.
Chemical Influence on Synaptosomal
K+- Dependent Phosphatase Activity
In the assay for the K+- phosphatase activity of the synaptosomal
membrane chlorpromazine was found to be an effective inhibitor of
this enzymatic process (Figure 13) .

The degree of inhibition was

seen to be directly proportional to the chlorp romazine concentration

of the assay .

The graphical presentation of this effect shows a

linear decrease in enzyme activity over the concentration range

tested , 10

-5

- 10

-3

occur at 8.4 x 10-

M.
5

The IC

50

for this inhibitio n was observed to

M chlorpromazine.

Although the enzyme inhibition

was dependent on the concentration of the drug it could not be
determined from the data whether chlorpromazine was capable of
producing a complete enzyme inhibition .
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Figure 13.

Measurement of synaptosomal K+- dependent phosphatase
in the presence of various concentrations of chlor promazine. Enzyme activity determined at J70C with
3-0-methy lfluorescein phospha te (1.0 ~M) as substrate.
S.E.M. for data collected with 2- 3 MCM preparations
indica t ed by crossbars, ci rcles without bars represent
individual observations.
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CH HgCl was found to be a more potent inhibitor of the phos3
6
phatase activity than clorpromazine with an rc
of 1.5 x 10- M
50
(Figure 14).

The effective concentration range for inhibiting the

phosphatase activity was 5 . 0 x 10

-5

- 1 . 0 x 10

-7

M CH HgCl.
3

The

concentrations used for this determination provide a well balanced
group of values that indicated the synaptosomal enzyme activity to
be directly proportional to the CH HgCl concentration of the assay .
3
Hg(N0 ) was determined to be the most potent inhibitor of the
3 2
phosphatase.

As can be seen in Table 7 it was 50 times more potent

than either CdC1

2

or CH HgCl, and 400 and 2600 times as effective
3

as Kepone or chlorpromazine, respectively.

Figure 15 reveals the

initial inhibition to be related to the concentration of the
compound in the assay while the lowest concentration of Hg(N0 )
3 2
8
tested, 3.0 x 10- M, sharply departed from the linear relationship.
CdCl

2

was also a potent inhibitor of the K+-dependent phos-

phatase wi th an

rc 50

of 1.5 x 10-

6

M (Table 7).

Figure 16 expresses

the inhibitory relationship as being linear throughout the range

of concent rations tested (10 ~ -10 ~ M) .

In comparing the CdC1

2

and

CH HgCl inhibitions it was evident that their effects on the synap3
tosomal phosphatase activity was identical with the

rc 50

of 1.5 x 10

-6

M for each and the shape of the line connecting the points in Figures

14 and 16 very similar.
Kepone, at 3.33 x 10- 4 M, completely inhibited the phosphatase
enzyme (Figure 17).

The

rc 50

for this inhibition was 1.3 x 10-S M

and Kepone, like chlorpromazine, CH HgCl and CdC1 , inhibited the
2
3
enzymatic cleavage of phosphate from the substrate in a manner that
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10 - 5

Figure 14.

Measurement of synaptosomal x+-dependent phosphatase
activity in the presence of CH3HgCl. Phosphatase
activity de termined at 37°C with 1.0 ~M 3- D-methyl fluorescein phosphate as substrate. S.E.M. for
data collected from 2-3 MCM preparations indicated by
crossbars. Circles without bars represent individual
observations.
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Table 7.

Concentration of test compound producing 50 percent
inhibition (ICso) of synap t osomal NE or SHT uptake or
K+- dependent phosphatase activity.

Chemical

ICSO (uM)
K+- dep . phosphatase

NE

SHT

CH HgCl

110

250

1.50

Hg(N0 )
3 2

400

600

0.03

3

CdC1

a

1.50

2

Kepo ne

94

330

l3

11

32

84

Acrylamide
DFP

Pa r aoxon

Chlorpromazine
Ouabain

110

alnsufficient inhibi t ion for detection of

rc 50 .
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100

~

80

2
c

60

..
0

-

(j

40

20

Figure 15.

Hg(N03)z inhibition of synaptosomal ~-dependent
phosphatase. Enzyme activity determined at 370C
with 1.0 ~M 3-0-methy lfluorescein phosphate as
substrate. S.E.M. for data collected from 2-3 MCM
preparations indicated by crossba rs . Circles wi.t hout
bars represent individual observat ions .
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100

80

2

60

c

0

u

*

40

20

CdCiz. (M)

Figure 16 .

Measurement of synaptosomal K+-dependent phosphatase
in the presence of various concentrations of CdClz.
Phosphatase activity determined at 37°C with 1.0 ~M
3- 0-methylfluorescein phosphate as substrate.
Crossbars designate the S.E.M. for data collected
from 2- 3 MCM preparations .
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10 0

-
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c

0

0

2
60

..
0

u

0

2:

40

£

I

20

10

10 - 5

t<e r> on e , (M)

Figure 17.

Kepone inhibition of s ynaptosomal K+-dependen t
phosphatase . as measured in the presence of 1.0 ~M
3-0- methylfluorescein phosphate at 37oc. S.E.M. for
data collected from 2-3 MCM prepa rat ions designated
by crossbars, circles without bars represent individual
observati ons.
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was proportional to the concentration of Kepone in the assay.
Kepone exerted its inhibitory influence over a wide concentration

range, 10

- 7- 10 - 3 M, which was also true for the other compounds that

strongly inhibited this enzyme.
The information presented in Table 8 shows acrylarnide, paraoxon,

DFP and ouabain to be ineffective in depressing the synaptosomal
phosphatase activity .

Although ac r ylamide shows a 15 - 20 percent

4
6
inhibition of this activity between 10- - 10- M and ouabain produces
a 24 percent inhibition of 3.0 x 10-

4

M these decreases were not

found to be of statistical significance.
Table 7 compares the

rc 50 •s

dependent phosphatase activity.

+

for NE and 5-HT uptake and KFrom this information chlorpromazine,

used as a positive control for the uptake inhibition, had the lowest

rc 50

for both the NE and 5- HT transport processes while it was the

least effective phosphatase inhibitor

of the compounds that were

able to reduce this activity more than 50% of the control.

Hg(N0 ) ,
3 2

on the other hand, was the least effective inhibitor of the uptake
processes, of those inhibiting this function by more than 50 percent,

yet it was the most effective inhibitory agent on the K+- dependent
phosphatase by several orders of magnitude.

Ouabain , another

positive control, inhibited NE uptake but surprisingly was not
effective against the 5- HT uptake mechanism or the phosphatase
enzyme of the membrane.
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Table 8.

Chemical
Acrylamide

Paraoxon

DFP

Ouabain

Test compounds producing only mild inhibition of
synaptosomal ~-dep enden t phosphatase.
Concentration (M)

3.33

X

3.33

X

3.33

X

3.33

X

3.33

X

6.67

X

3.33
3.33

10- 5
10- 4
10- 5
-4
10

% Control

87
83
96
96

10- 4
10- 4

97

X

10- 5

100

X

10- 4

76

96
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DISCUSSION
This study was undertaken to determine what influence a select
group of environmental pollutants exerts on synaptosomal inactivation
of norepinephrine (NE) and 5- hydroxytryptamine (5- HT).

The test

chemicals used in this study were CH HgCl, Hg(N0 ) , CdC1 ,
2
3 2
3
diisopropylfluorophosphate (DFP), paraoxon, acrylamide, and Kepone.
In addition to the examination of the uptake process after in vitro
exposure to the test compounds the Na, K+ gradient was indirectly
monitored in the synapotsomal membranes by determining the K+dependent phosphatase activity in the presence and absence of the
test chemicals.

Since the uptake process is dependent on the

transmembrane Na+ gradient the monitoring of this gradient was able
to provide information to help assess whether the chemical influence
on the memb r ane transport process is specific in nature or the result
of non- specific membrane interactions.

Prior to the actual examination of the uptake activity in the
presence of the test chemicals it was necessary to determine the
suitability of the synaptosomal preparations for the study .

This

was accomplished by first determining the optimum conditions for
the uptake assay (time, synaptosome concentration and neurotransmitter concentration) then by obtaining the Km and Vrnax for each
uptake process .

Once these Km and Vrnax values were obtained they were

compared to the previously reported values of Cahill and Medzihradksy
(1976).

After this comparison chlorpromazine and ouabain were

used as positive inhibitors of the membrane uptake to further
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determine th e suitability of the synaptosomal preparations for use
in this study.
Suitability of the Synaptosomal
Preparations for Up take Studies
Since the first isolation and characterization of synaptosomes,
their usefulness for increasing the understanding of synaptic transmission has been widely accepted.
incorporate

Most procedures for their isolation

differential and density-gradient centrifugation as

a necessary step in their purification.

However, Cahill and

Medzihradsky (1 976) devised a method which only requires differential
centrifugation to isolate what they refer to as the "mod ified crude
mitochondrial" fraction (MCM).

They have shown this MCM fraction

to be capable of carrying out the same functions as the more purified
synaptosomal preparations.

Not only does this procedure shorten the

preparation time but it also reduces the handling of the synaptosome
fraction and the possibility of membrane lysis that might occur under
a more extensive isolation procedure.

In Table 2 t he Km and Vmax for the transport of NE and 5-HT are
listed.

NE has a single high affinity process with a Km of 1.1

and a Vmax of 4 .65 pmo l es/mg prot./min.

~M

5- HT uptake occurs via

t wo separate transport phenomena wi th t he high affinity process
being the most active at low substrate concentrations with a Km and
Vmax of 0 . 40

~M

and 2.54 pmoles/mg prot./min, respectively.

low affinity uptake is characteriz ed by a Km and Vmax of 3.64
and 10.0 pmoles/mg prot./min, re sp ectively.

The
~M

Cahill and Med zihradsky

(1976) lis ted the Km for the NE up take as 0.39

~M

wh ile the 5- HT
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Km is 0.1

M for the high affinity uptake, Vmax's are 2.9 and 3.0

pmoles /mg prot./min for NE and 5-HT, respectivel y .

The quantitative

difference between this study and the Cahill study may well be due
to the manner in which the uptake assay's were terminated .

This

study employed a centrifugation step, after transferring the 37°C
samples to an ice- bath, to pellet the synaptosomes while the Cahill
procedure called for vacuum fil t ration as the terminating step in
the assay.

It is possible that the filtration technique allows for

a more complete removal of any radio-labelled amine that is nonspecifically adhering to the synaptosomes than is possible by a
similar clean- up procedure utilizing centrifugation.
In assessing the subcellular distribution of NE after uptake
into the MCM it was determined that greater t han 95 percent of t he
amine was located in the synap t osomal fraction (Table 3).

In

conjunction with this finding is the demonstration that the addition
of pargyline to the incubation media had no enhancing effect on NE
or 5- HT uptake (Table 4).

Since pa r gyline is a monamine oxidase

inhibitor and as such would prevent the metabolism of NE or 5- HT
by mitochondria , consequently increasing the amine concentration

available for up t ake, this result is evidence that mitochondrial
contamination of the HCM does not interfere to a significant extent
with the synaptosomal uptake.
The determination of the synaptosomal LDH ratio ( intra- /ex trasynaptosomal) did not prove to be useful as a normalization factor
for comparison of da ta from different sample preparations (Table 5),
however, t his LDH ratio is useful if used as an indicator of memb rane

74
intac tness.

The r a tios presented in Table 5 suggest that very intact

synaptosomal membranes were present .

Greater than 80 percent of the

LDH activity occurred in the intra-synapto somal compartment in almost
all preparations.

The data presented here indicate that the synapt -

osomes isolated for this study had a greater degree of membrane
intactness than the synaptosomes used in the Cahill and Medzihradsky
(1976) study where 30 percent of the LDH activity was present in the
extra-synaptosomal medium.

Although the LDH ratio is a good indicator

of membrane integrity it unfortunatel y does not appear to be useful

in assessing the functionality of the isolated synaptosomes.

Because

of this all uptake data is report ed as percent of con trol uptake
rather than a direct comparison of the actual uptake values.
Chemical Influence on Synaptosomal Uptake
Modification of synaptic inac t ivation of NE and 5-HT uptake
is one means of producing behavioral changes in both animals and
man.

Chlorpromazine,. a commonly used anti- psychotic drug, is believed

to work through such a mechanism (Brucke et al., 1969; Koelle, 1975).
In this study a variety of environmental pollutants were tested for
this activity and the results obtained indicate that seve ral have

such a capability.

Table 7 lists the concentration of test chemical

producing 50 percent inhibition of NE or 5-HT uptake for all the
compounds investigated .

The two mercurials, methylmercuric chloride

and mercuric nitrate , and the cyclodiene insecticide Kepone were

t he only compounds tested , other than t he positive controls, that
were able to produce greater than 50 perc ent inhibition of this
process .

Acrylamide, DFP and paraoxon induce a sligh t bu t
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statistically insignificnt inhibition (Table 6).

The

for the mercurials and Kepone were greater than 10-

5

rc 50

values

M indicating

that this inhibition is not specific for the carrier-mediated transport of the biogenic amines.

With respect to Kepone, End et al. (1979b) demonstrated a
synap tosomal membrane disruption at 10-

5

M that was characterized

by a Ca++ efflux and leakage of LDH into the assay media.

With

electron microscopy they also noted that Kepone produced a direct
membrane lysis that apparently led to the LDH and Ca++ liberation.
In another study Ho et al. (1980) noted that Kepone decreased
catecholamine and 5-HT uptake, after both in vitro and in vivo
exposure, into mouse synaptosomes.

Using a Scatchard analysis they

revealed that Kepone reduced the affinity of the transmitter towards
the ligand as well as the maximum amount of binding.

These studies

suggest that Kepone was able to alter the uptake of the biogenic
amine in two ways, the first is membrane perturbation, resulting in

a loss of the ionic gradient that is required for membrane transport
thus reducing the effectiveness of the carrier- mediated process.

The second mechanism is possible through a direct interaction of
Kepone with the neurotransmitters membrane receptor ihibiting the
transmitter binding to the uptake site.
Mercurials are also known to specifically bind to membranes

(Chang and Hartman, 1972c), in part this may be a function of their
high affinity for sulfhydryl groups as well as a lesser affinity for
amino, phosphate, carboxylate and hydroxyl radicals (Oehme, 1978).
Mercury compounds accumulating in the region of the synapse would be

76
expected to readily associate with membrane components.

Such an

interaction could ultimately result in the loss of membrane function
as is evidenced in

th~s

study of biogenic amine transport.

Since

the neurotransmitters have f unctional gr oups that are capable of
complexing the mercury, direct interaction with the transmitter

may enhance the inhibition of the uptake process.
interaction

~th

If such a direct

transmitters was to occur physiologically in exposed

animals the transmitter-metal complex would not only affect the
inactivation process of the amines but would also have a specific and
possibly more dramatic effect on post-synaptic interaction of the
neurotransmitters and their membrane receptors .

In examining the information contained in Figures 10, 11 , and
12 it is noted that the mercurials and Kepone have a very narrow
4
effective range (10- -10-J !1) where significant uptake inhibition
is detected .

Such a narrow concentration range is suggestive of an

all - or - none mechanism where uptake inhibition occurs only after high
enough concentrations are present t o produce membrane pe rturbations.
If complexing of neurotransmitter and toxicant were occurring it

would be expected that a muc h greater dose- response effect would be
seen .

Extending the relationship further it might be argued that

these chemicals do not produce a chronic toxicity by acting at the
synapse because the hi gh concentrations required to disrup t the
system are higher than one might expect to accumulate during chronic
low- level exposures .
With the other compounds, DFP, paraoxon , acrylamide and CdC1 ,
2
a direct effect to influence synaptosomal uptake of t he transmitters does not appear to occur .

A significan t modification of the

77
uptake process was not seen wh'en tested for in the presence of these

compounds.

For DFP and acrylamide this is somewhat unexpected

considering they both appear to act, at least partially, at the
membrane level in eliciting a toxic response.

DFP is known to

readily phosphorylate membrane components (Johnson and Lauwerys,
1969) and it might have been anticipated that such phosphorylations
would affect the uptake process, if not directly then indirectly
by influencing the synaptosomal energy generation that is apparently
required for membrane transport to occur.

Although acrylamide

initiates axonal degeneration it is still undecided whether this
is a direct membrane effect or an indirect result of inhibition of
axonal respiratory enzymes as recently suggested by Spencer et al.
(1979).
K+-Dependent Phosphatase Nodification
by Environmental Pollutants
K+-dependent hydroloysis of organic phosphate is catalyzed by
membrane preparations highly enriched in (Na+,K+)-activated
adenosinetriphosphatase (Na+, K+-ATPase) (Bader and Sen, 1966;
Judah et al., 1962).

Nore recently it has been found that in the

purification of the Na+, K+-ATPase enzyme, from a variety of different

+

sources, the K -dependent phosphatase activity remains associated

with the enzyme and is actually purified along with it (Jorgensen
et al., 1971; Pitts et al., 1973; Uesugi et al., 1971).

In fact,

it has been accpeted that the K+- dependent phosphatase activity is a
property of the Na+, K+-ATPase (Hokin

et al., 1973; Kyte, 1971;
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Lane et al., 1973).

Monitoring of this enzyme activity in synapt-

osomal preparations, and in the presence of the environmental

pollutants investigated in this study, gives an indication of the
influence that these chemicals have on the Na+ gradient required for
synaptosomal membrane transport.
Table 7 indicates that the heavy metal CH HgCl, Hg(N0 ) and
3
3 2
CdC1

2

as well as Kepone and chlorpromazine produced greater than

50 percent inhibition of this enzyme.

Hg(N0 ) is considerably more
3 2

potent in this respect than the others, but CH HgCl and CdC1 also
3
2
strongly inhibit the phosphatase at very low concentrations.

This

is in general agreement with other workers who indicate that heavy
metals are very e f fective in modulating Na+, K+- ATPase activity (Bond
and Hudgins , 1979; Henderson et al., 1971; Karlish et al . , 1979;
Kinter and Pritchard , 1977).

Kepone inhibition of the phosphatase

activity is also in agreement with the finding that, as a class,
organchlorines are effective inhibitors of ATPase (Glick, 1973).
Chlorpromazine was the weakest of the inhibitors producing greater
t han 50 percent inhibition, requiring almost a 1 . 0 mM concentration
to reduce the phosphatase to a half maximal rate.

Ouabain, which

is generally considered a highly specific inhibitor of Na+ , K+ATPase, was found to be a poor inhibitor in this system.
less than 25 percent inhibition of this activity occurred.

At 0 . 33 mM
This is

possibly due to the lack of Na+ ions in the incubation medium and
the high K+ concentrations present (10 mM).

It is also possible

that the enzyme substrate used, 3-0- methylfluorescein phosphate,
does not support ouabain binding to the enzyme because of a higher
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affinity for the binding site.

Acrylamide, DFP and paraoxon did not

demonstrate any inhibitory activity in this system.

Althoudh DFP,

like other organophosphates, is considered to be a good enzyme
inhibitor (Lehninger, 1975), it is apparent that the K+-dependent
phosphatase activity, as examined in this study, is not adversely
affected by any protein phosphorylation initiated by DFP.
Comparison of the Biogenic Amine Uptake and
K+-Dependent Phosphatase Inhibition
by Environmental Pollutants
Examining Table 7 closely it is evident that a correlation between
uptake inhibition and K+-dependent phosphatase activity does not
exist.

The inorganic mercurial, Hg(N0 ) , was the strongest inhibitor
3 2

of the phosphatase activity but the weakest inhibitor of the uptake
process of the chemicals capable of producing greater than 50 percent
inhibition.

Chlorpromazine had just the opposite properties, being

the most effective uptake inhibitor but the weakest of the positive
phosphatase inhibitors .

CdCl , on the other hand, was very effective
2

against the phosphatase enzyme but totally ineffective in inhibitin g
either uptake process and DFP which would be expected to exert a
strong influence on any enzymatic process has no influence, even at

a 10- 3 M concentration, on either the synaptosomal uptake or phos phatase properties of the membranes .

Although a correlation does not

occur between the phosphatase and uptake function of the synaptosomal
membrane , this data indicated that several of these environmental

pollutants were highly effective inhibitors of enzymatic processes
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(as evidenced by the low

rc 50 •s

for the phosphatase).

This would be

of critical importance to synaptic, as well as neuronal function,

if the test compounds were able to permeate the plasma membranes and
gain access to the intracellular compartments.

It should be noted that the lack of an inhibitory influence for
DFP was unexpected.

As previously mentioned DFP is considered to be

a good inhibitor of many enzymatic processes and Saunders (1957)
estimated the

rc 50

for horse-serum cholinesterase at 10

-9

M DFP.

+

+

Contrasting results have been reported for DFP effects on Na , K ATPase isolated from rat brain .

Glow et al. (1972) reported that expo-

sure to sublethal doses of DFP in vivo increased the Na+, ~-ATPase
specific activity of whole brain homogenates while decreasing

+

+

activities were found in Na , K -ATPase of rat cerebral cortices

(Jovic et al., 1971).

\fhatever the reasons for the qualitative

differences in these two studies may be, the important point is that
DFP did alter the Na+, K+-ATPase.

Since K+- dependent phosphatase is

considered to be a property of the Na+, K+-ATPase, the lack of effect
exhibited by DFP on this enzyme was unexpected.

A more extensive

examination of the kinetics of the phosphatase would be useful in
elucidating the extent of this ineffectiveness.

The Significance of the Effects Environmental
Pollutants Have on Rat Synaptosomal Membrane
Function and Suggestions for Future Studies
In examining the inhibition of the uptake process at various
concentrations of toxicant it was concluded that at relatively high
concentrations, CH HgCl, Hg(N0 ) and Kepone were effective inhibitors.
3
3 2
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This low affinity inhibition suggests that a specific inhibition of
the carrier-mediated transport may not exist .

Rather, a non- specific

membrane interaction may be the mechanism by which such inhibition
occurs.

The lipophilic nature of these compounds may allow for their

insertion within the membrane, with subsequent interaction with

membrane phospholipid or protein , leading to a disruption of the
inherent order and functionality of the membrane.
The information collected indicates that a correlation between
inhibition of rat brain synaptosomal uptake and K+-dependent membrane
phosphatase does not exist.

To account for this lack of correlation

it is possible that the rat is not a sensitive enough species for such
studies.

It is widely accepted that the chicken is the species of

choice for studies involving neurotoxic pathology because of its
sensitivity to chemicals inducing such effects .

Although it can be

shown that rats and other rodents are susceptible to chemically
induced neuropathies it is generally accepted that they are less
sensitive than other species (i . e. , chicken).

Therefore , it is

possible that a study of this nature performed with chicken synatposome preparations may yield a more positive correlation .

The results of this study also suggest that inhibition of
synaptosomal neurotransmitter uptake is not a key factor in the
neurotoxicity of the compounds tested.

However , in vivo exposure of

animals to these compounds followed by analysis of the uptake functions
would be a much stronger indicator· of the existence as well as the
significance of such an effect.

It would also be of relevance to

examine the nature of the interaction between these compounds and the
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biogenic amines to determine whether a toxicant - amine complex formation

occurs.

Such a complex would be capable of directly influencing the

information transfer that occurs across the synapse.

Other in vitro

- -- -

studies that may provide s i gnifican t information in assessing the
potential toxicity of these compounds would include an examination

of the actual membrane interaction that was postulated to occur .
This could be accomplished by monitoring membrane fluidity as well
as passive diffusional transport for changes in membrane permeability.
It would also be of interest to determine whether these compounds
actually permeate the membrane and accumulate within the intra-

synaptosomal compartment.

If this were to occur it may ultimately

prove to be more critical for synaptic function since these neuortoxic

compounds would then have access to the metabolic and synthetic
machinery of the synaptic terminal and the concentration necessary

to disrupt this activity would likely be much less than that necessary
for memb r ane disruption.
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SUMMARY AND CONCLUSION
This study was undertaken t o determine if the neur otoxicity
produced on exposure to several environmental pollutants could be
attributed to membrane changes occuring at the synaptic processes
of the central nervous system.

An in vitro model system was used to

determine if membrane changes were capable of being produced on
in vitro expso ur e to CH HgCl , Hg(N0 ) , CdCl , DFP , paraoxon,
2
3 2
3
acrylamide, and Kepone.

Synaptosomal uptake of norepinephrine and

serotonin, as well as the membrane K+- dependent phosphatase activity,
were mon itored as indicators of membrane function.

The data presented indicates that the two mercurials , CH HgCl
3
and Hg(N0 ) , and the cyclodi ene insecticide Kepone , were effective
3 2
i nhibitors of both the NE and SHT carrier- mediated uptake with more
than 50 percen t inhibition occurring at concentrations greater t han

10 -

4

M.

The remaining test compounds were unable to induce a signi -

ficant inhbition of this process at concentrations ranging up to
10 - 3 M.

Although CH HgCl, Hg(N0 ) and Kepone produced a significant
3 2
3

inhibition it should be noted that the Km's for the high affinity
NE and 5-HT transport was established to be less than 10- 6 M.
high

rc 50

The

values presented for these compounds as well as the

demons tration that their effectiveness occurred over a narrow
concentration range suggests a non- specific membrane perturbation as

the initiating factor eliciting the inhibitory response.
The K+- dependent phosphatase was strongly inhibited by Kepone,
CH HgCl, Hg(N0 ) , and CdCl .
2
3
3 2

The

rc 50

values were determined to be
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less than 10

-5

Mwith Hg(N0 ) having the strongest inhibitory influence.
3 2
3
DFP, paraoxon and acrylamide at concentrations up to 10- M were
unable to produce a significant inhibition of the phosphatase.
Since the NE and SHT uptake is at least partially dependent on
the energy generated from the Na+, K+ transmembrane gradient it was
felt that the low affinity inhibition of the uptake processes might
be a result of a direct effect on the cation gradient.

Although

the inhibition of the membrane phosphatase did occur at very low
concentrations of the test chemicals a correlation between this
inhibition and the monoamine uptake inhibition could not be
demonstrated .
The data generated from this investigation indicates that
inhibition of the synaptosomal NE and SHT uptake on in vitro
exposure to CH HgCl, Hg(N0 ) and Kepone, is not a c.ritical factor
3
3 2
in the neurotoxicity produced by these compounds.

The high concentra -

tions and narrow dose- response curves suggest a direct membrane

effect as the causative factor in the inhibitory response.

Although

the uptake inhibition was not demonstrated to be a highly specific
process, inhibition of the K+- dependent phosphatase was found to
occur at sub- micromolar concentrations.

This suggests that these

compounds are able to influence synaptic membrane function and the
possibility of other synaptic effects can not be ruled out.
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